EAS Newsletter August 6, 2024

Publications:

EAS Consensus position statements are readily available at your fingertips

The EAS Consensus Panel, comprised of internationally renowned experts in atherosclerosis and cardiovascular disease, was first convened in November 2009 to consider the evidence for non-LDL lipids as risk factors for cardiovascular disease. To 2020 the Panel was co-chaired by Prof John Chapman (France), Prof Henry N. Ginsberg (USA), and Prof Alberico L. Catapano (Italy).

From 2021 a new structure for the EAS Consensus Panel has been created, with coordination by Prof Alberico Catapano (Italy), Prof Lale Tokgözoğlu (Turkey) and Prof Kausik Ray (Imperial College London, UK). For each position paper topic, two or more independent chairs are appointed. These then drive the focus and content together with experts from around the world with the relevant expertise in that topic.

Taking over the role of Consensus Panel coordinators for forthcoming position papers are Prof Marianne Benn (Denmark), Prof Christoph Binder (Austria), Prof Stefano Romeo (Sweden) and Prof Jeanine Roeters van Lennep (The Netherlands).

Our Society brings together experts in Consensus Position Panels, whose reviews of emerging research topics in the field of atherosclerosis and cardiovascular disease are published as Consensus position statements. Explore them today.

Society:

Apply for an EAS Competitive grant before September 13

Submit your application for an EAS Competitive Grant before the deadline on September 13, 2024. Ensure you carefully review the eligibility criteria, funding terms, and conditions listed below before applying.

If you have any questions, please feel free to contact us.

Education:

Join us for our third LatAm webinar and help set a new attendance record

Join us for the third webinar in our exciting EAS-LatAm series and help us set a new attendance record!

Our expert speakers will delve into the following fascinating topics:

🟫 Potential atherogenicity of triglyceride-rich lipoproteins by Laura Schreier
🟫 TG-rich lipoproteins: star or second field in residual CV risk? by Alberto Zambon

Don’t miss this opportunity to gain valuable insights and be part of a record-breaking event!

Education:

Featured Open Lecture: Gene therapy in lipid metabolism and CVD by Prof. Sekar Kathiresan

Looking for an insightful weekly video? Don’t miss our top pick! In this Featured Open Lecture, Prof. Sekar Kathiresan delves into the latest breakthroughs in gene therapy for treating dyslipidemia and preventing heart attacks.